Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/01/2003US20030082714 Novel nucleic acid and polypeptide
05/01/2003US20030082713 Detection of preferential nucleotide sequences in sample; obtain nucleotide sequences sample, incubate with labeled oligonucleotide, denature, monitor chemiluminescence emission and compare to control
05/01/2003US20030082712 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082710 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082708 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082707 Membrane protein for use as tool in human therapeutics and diagnostics
05/01/2003US20030082706 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082705 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082704 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082703 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082702 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082701 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082698 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082697 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082696 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082695 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082694 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082693 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082692 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082691 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082690 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082689 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082687 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082686 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
05/01/2003US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
05/01/2003US20030082682 Nucleotide sequences coding polypeptide for use in the treatment cancer, osteoporosis, fertility defects, endometriosis, inflammatory, nervous system, skin and cardiovascular disorders
05/01/2003US20030082676 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer
05/01/2003US20030082675 Expression vector for use as gene therapeutic tool
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082673 Homologous recombination expression vector for use as tool in the expression of recombinant genes in rodent cells
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082668 Method for measuring the activity of deacetylase and method of screening for inhibitors and accelerators of the enzyme
05/01/2003US20030082657 Oomycete FtsZ-mt as a target for oomycete-specific antimicrobials
05/01/2003US20030082656 Nucleotide sequences for use in the detection of pseudomonas bacteria
05/01/2003US20030082650 Great gene and protein
05/01/2003US20030082648 Novel mass receptor-analogous protein and dnas thereof
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082642 Transgenic mammalian cells for use diagnostic tool in monitoring cell activities
05/01/2003US20030082641 A method of treating depression using a galr3 receptor antagonist
05/01/2003US20030082639 Detecting herbicidal activity associated with test compound; obtain test sample, incubate with polypeptide, monitor and evaluate activty test compound
05/01/2003US20030082636 Antibody for use as tool in the treatment of blood disorders
05/01/2003US20030082634 Novel cell regulation factor TTO 20
05/01/2003US20030082630 Combinatorial libraries of monomer domains
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082619 Contiguous and partially overlapping cDNA sequences and polypeptides
05/01/2003US20030082615 Olfactory receptor expression libraries and methods of making and using them
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082611 Methods and compositions for cellular and metabolic engineering
05/01/2003US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics
05/01/2003US20030082605 Genomic DNA detection method and system thereof
05/01/2003US20030082604 Preparation of microarray for use in the detection of preferential particles in sample; form solid support, incubate with nucleic acids conjugated to photoreactive group, illuminate applied spot, compare pattern to controls
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082600 Highly sensitive method for the detection of cytosine methylation patters
05/01/2003US20030082599 Polynucleotide
05/01/2003US20030082598 Molecular interaction sites of 23S ribosomal RNA and methods of modulating the same
05/01/2003US20030082597 Age-associated markers
05/01/2003US20030082595 Nucleotide sequences coding polypeptide for use in preparation of foods and flavorings
05/01/2003US20030082591 Methods for gene disruption and uses thereof
05/01/2003US20030082590 Exponential nucleic acid amplification using nicking endonucleases
05/01/2003US20030082585 Novel receptors
05/01/2003US20030082584 Detecting gene expression in sample; obtain nucleotide sequence sample, incubate with labelled probe, detect signal from sample, determine intensity signal
05/01/2003US20030082581 Dual RT procedure for cDNA synthesis
05/01/2003US20030082580 Isolation of trangenic plant with suppressor activity; prepare nutrient broth, culture plant in broth, transform plant, evaluate a nd recover plants with suppressive phenotypes
05/01/2003US20030082579 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity
05/01/2003US20030082578 In vitro amplification of nucleic acid molecules via circular replicons
05/01/2003US20030082576 Detection of polymorphic nucleotide sequences; obtain nucleotide sequences, incubate with solid substrate containing primers, a mplify sequences, incubate with probe, detect signal, analyze polymorphic sequences
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082572 Methods and compositions for nucleotide analysis
05/01/2003US20030082571 Linear nucleic acid and sequence therefor
05/01/2003US20030082570 High-throughput transcriptome and functional validation analysis
05/01/2003US20030082567 Mineral hot start PCR method
05/01/2003US20030082565 Preparing kit for amplification of nucleotide sequences; obtain container, fill with solid support, cover, seal recover package
05/01/2003US20030082561 Generation of artifical transcription factor; prepare library of artficial transcription factors, screen library, recover clone demonstrating gene modulation activity, amplify clone
05/01/2003US20030082559 Amplification of target nucleic acid sequence in cell; obtain nucleotide sequences from cells, incubate with primer and amplification mixture, amplify, remove preferential sequences and amplify , recover amplified sequences
05/01/2003US20030082558 Preparation of labelled nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer, polymerase and and labelled amplification mixture, amplify, recover labelled nucleotide sequences
05/01/2003US20030082556 Binary encoded sequence tags
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082552 Recovering preferential segment of chromatin; obtain cellular chromatin, incubate with binding agent, map and recover segment of nucleotide sequence bound by agent
05/01/2003US20030082545 Quantitative analysis of cancer-associated mutations; genetic engineering
05/01/2003US20030082536 Genetic engineering; forming libraries of polynucleotide; screening
05/01/2003US20030082534 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of brain and psychological disorders
05/01/2003US20030082524 Isolation of peptide which immunologically mimics streptococci protein for use in vaccine development; prepare antibody sample, incubate with phage display library, detect bound phage, isolate and recover phage
05/01/2003US20030082518 Genetic engineering; quantitative analysis; medical diagnosis
05/01/2003US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator
05/01/2003US20030082514 Detecting active biopolymers in sample; provide vectors, transduce cells, recover transduced cells, propagate cells, detect adjusted phenotypes, sequence nucleotide acids in trangenic cells, isolated ligand for biopolymers
05/01/2003US20030082513 Detecting cell to cell activity in sample; obtain cells, polarize, incubate with fluorescent dye, determine membrane potential of cells, monitor adjustment in membrane potenial between cells
05/01/2003US20030082444 Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device
05/01/2003US20030082210 Sequence determination; calibration
05/01/2003US20030082205 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
05/01/2003US20030082204 Mixture of attenuated genetic engineered virus and carrier
05/01/2003US20030082202 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
05/01/2003US20030082201 Genetic engineering; polymerase chain reaction
05/01/2003US20030082200 Protein binding to immobilized vitronectin
05/01/2003US20030082198 Administering complex of heat shock protein and antigen